EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Yubo International Biotech Limited (YBGJ) had EBITDA Margin of -45723.95% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.00M |
|
$-1.78M |
|
$0.00M |
|
$0.00M |
|
$1.77M |
|
$-1.77M |
|
$-0.21M |
|
$-1.98M |
|
$-1.98M |
|
$-1.98M |
|
$-1.98M |
|
$-1.98M |
|
$-1.98M |
|
$-1.77M |
|
$-1.59M |
|
119.82M |
|
119.82M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.68M |
|
$0.21M |
|
$0.85M |
|
$1.53M |
|
$4.72M |
|
-- |
|
$0.11M |
|
$4.83M |
|
$-3.30M |
|
$-3.35M |
|
$-3.30M |
|
119.82M |
|
| Cash Flow Statement Financials | |
$-1.34M |
|
$0.12M |
|
$1.41M |
|
$0.01M |
|
$0.01M |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
76.31% |
|
-51006.31% |
|
-51006.31% |
|
|
EBITDA Margin |
-45723.95% |
-57112.16% |
|
-51161.47% |
|
$-1.22M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.02 |
|
0.02 |
|
0.02M |
|
60.10% |
|
59.19% |
|
-129.12% |
|
60.10% |
|
$-0.03 |
|
$-0.01 |
|
$-0.01 |
|